Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534401 · ClinicalTrials.gov registry record · NA
Addressing Reproductive Coercion in HEalth Settings - Kenya
A NA study of Intimate Partner Violence (IPV) and Family Planning, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 659
- Enrollment target
- 1
- Study location
NCT03534401: Completed NA study of Intimate Partner Violence (IPV) and Family Planning, sponsored by University of California, San Diego.
NCT03534401 is a NA study of Intimate Partner Violence (IPV) and Family Planning that has completed, run by University of California, San Diego. The registered enrollment target is 659 participants, above the 470-participant average among 5 other Intimate Partner Violence (IPV) trials with a reported enrollment target (40% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03534401, a NA study of Intimate Partner Violence (IPV) and Family Planning, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 659 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this research is to conduct a small matched cluster control trial of an intervention designed to address reproductive coercion and unintended pregnancy (ARCHES - Addressing Reproductive Coercion within Healthcare Settings) adapted to the Kenyan cultural and family planning healthcare context (ARCHES Kenya) so as to provide initial data regarding acceptability, feasibility and efficacy in this high-need LMIC context.
Primary Outcome
Binary (yes/no) measure based on 9-item indicator list (entitled the Reproductive Coercion Scale) assessing incidence of male partner behaviors that interfere with or prevent use of contraception or coerce pregnancy in prior 3 months. A "yes" response to any of the 9-items indicates reproductive coercion is present.
Conditions Studied
Interventions
- BEHAVIORAL ARCHES Kenya
Study Locations (1)
California
- Center on Gender Equity and Health, University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 659 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
What the finished NCT03534401 record still lists
NCT03534401 is an interventional study that assigns participants to a tested intervention. The registered 659 participants enrollment target is mid-sized for trials with a published cap, above the 470-participant average among 5 other Intimate Partner Violence (IPV) trials with a reported enrollment target (40% higher).
The record links to 3 conditions, with Intimate Partner Violence (IPV) appearing as the primary indexed condition, and to 1 intervention - of which ARCHES Kenya is the first listed.
NCT03534401 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03534401 about?
NCT03534401 is a clinical study titled "Addressing Reproductive Coercion in HEalth Settings - Kenya". The primary purpose of this research is to conduct a small matched cluster control trial of an intervention designed to address reproductive coercion and unintended pregnancy (ARCHES - Addressing Reproductive Coercion within Healthcare Settings) adapted to the Kenyan cultural and family planning hea...
What is the current status of trial NCT03534401?
This trial is currently completed. It is a NA study. The enrollment target is 659 participants. The study started on 2018-06-01. Estimated completion is 2020-12-01.
What conditions does trial NCT03534401 study?
This clinical trial studies the following conditions: Intimate Partner Violence (IPV), Family Planning, Unintended Pregnancy.
What interventions are being tested in trial NCT03534401?
The interventions under investigation include: ARCHES Kenya (BEHAVIORAL).
Who is sponsoring clinical trial NCT03534401?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03534401 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intimate Partner Violence (IPV)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
RECRUITING · NA
-
A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
RECRUITING · NA
-
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families
RECRUITING · NA
-
Get Better Together: Relationship Education For Military Couples
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07216742 · 659 participants · Phase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI